BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31815296)

  • 1. Splicing Regulator p54
    Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
    Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF1-dependent alternative splicing attenuates BIN1 expression in non-small cell lung cancer.
    Wang J; Liu T; Wang M; Lv W; Wang Y; Jia Y; Zhang R; Liu L
    J Cell Biochem; 2020 Feb; 121(2):946-953. PubMed ID: 31478261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p54nrb/NONO regulates cyclic AMP-dependent glucocorticoid production by modulating phosphodiesterase mRNA splicing and degradation.
    Lu JY; Sewer MB
    Mol Cell Biol; 2015 Apr; 35(7):1223-37. PubMed ID: 25605330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
    Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
    Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
    Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
    RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of bridging integrator 1 (BIN1) as a potential tumor suppressor and prognostic marker in hepatocellular carcinoma.
    Pan K; Liang XT; Zhang HK; Zhao JJ; Wang DD; Li JJ; Lian Q; Chang AE; Li Q; Xia JC
    Mol Med; 2012 May; 18(1):507-18. PubMed ID: 22281836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear scaffold protein p54
    Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
    Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy.
    Fugier C; Klein AF; Hammer C; Vassilopoulos S; Ivarsson Y; Toussaint A; Tosch V; Vignaud A; Ferry A; Messaddeq N; Kokunai Y; Tsuburaya R; de la Grange P; Dembele D; Francois V; Precigout G; Boulade-Ladame C; Hummel MC; Lopez de Munain A; Sergeant N; Laquerrière A; Thibault C; Deryckere F; Auboeuf D; Garcia L; Zimmermann P; Udd B; Schoser B; Takahashi MP; Nishino I; Bassez G; Laporte J; Furling D; Charlet-Berguerand N
    Nat Med; 2011 Jun; 17(6):720-5. PubMed ID: 21623381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONO and tumorigenesis: More than splicing.
    Feng P; Li L; Deng T; Liu Y; Ling N; Qiu S; Zhang L; Peng B; Xiong W; Cao L; Zhang L; Ye M
    J Cell Mol Med; 2020 Apr; 24(8):4368-4376. PubMed ID: 32168434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
    Xie R; Chen X; Cheng L; Huang M; Zhou Q; Zhang J; Chen Y; Peng S; Chen Z; Dong W; Huang J; Lin T
    Mol Ther; 2021 Jan; 29(1):291-307. PubMed ID: 32950106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.
    Ding H; Liu J; Wang C; Su Y
    Cancer Cell Int; 2020; 20():425. PubMed ID: 32884448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.
    Ge K; DuHadaway J; Du W; Herlyn M; Rodeck U; Prendergast GC
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9689-94. PubMed ID: 10449755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p54
    Yamamoto R; Osawa T; Sasaki Y; Yamamoto S; Anai M; Izumi K; Matsumura Y; Sakai J; Aburatani H; Mizokami A; Kodama T; Tanaka T
    Oncotarget; 2018 Feb; 9(12):10510-10524. PubMed ID: 29535823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.
    Wechsler-Reya R; Sakamuro D; Zhang J; Duhadaway J; Prendergast GC
    J Biol Chem; 1997 Dec; 272(50):31453-8. PubMed ID: 9395479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.
    Kuwahara S; Ikei A; Taguchi Y; Tabuchi Y; Fujimoto N; Obinata M; Uesugi S; Kurihara Y
    Biol Reprod; 2006 Sep; 75(3):352-9. PubMed ID: 16641145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
    de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
    Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
    Pellarin I; Dall'Acqua A; Gambelli A; Pellizzari I; D'Andrea S; Sonego M; Lorenzon I; Schiappacassi M; Belletti B; Baldassarre G
    Oncogene; 2020 May; 39(22):4390-4403. PubMed ID: 32332923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional activation of human CYP17 in H295R adrenocortical cells depends on complex formation among p54(nrb)/NonO, protein-associated splicing factor, and SF-1, a complex that also participates in repression of transcription.
    Sewer MB; Nguyen VQ; Huang CJ; Tucker PW; Kagawa N; Waterman MR
    Endocrinology; 2002 Apr; 143(4):1280-90. PubMed ID: 11897684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.